Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

metastatic Male Breast Cancer

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Treatment of Metastatic Male Breast Cancer

Broader topic: Male Breast Cancer

Source population
Not part of this definition
Disease extent
metastatic
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Scoped from an NCI treatment-summary heading. NCI PDQ is an evidence summary, not a practice guideline, and only the dimensions the heading states are part of this definition.
      source wording
      Treatment of Metastatic Male Breast Cancer

      Study evidence for this setting

      2 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT01037790 · Registry condition search · Scope: unclear

      Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

      1 outcome links · 5 safety-group records · 0 quality-of-life measures

      →

      NCT01806675 · Registry condition search · Scope: unclear

      18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

      5 outcome links · 3 safety-group records · 1 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
        mappings

          Download this complete draft source relationship record →

          Preserved source evidence · Not medical advice